gallium-68

gallium-68

n.
A positron-emitting nuclide having a half-life of 1.13 hours, used as a tracer in brain scanning.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Gallium-68 is a radioisotope that is produced from a 68 Ge/68 Ga generator.
Ivanic also added that the delivery of equipment has been agreed in Banja Luka for the gallium-68 laboratory used in diagnostics in nuclear medicine and that the Veterinary Faculty in Sarajevo and the Institute 'Dr.
For diagnostic application, medical radioisotopes with short half-lives, like Gallium-68, are combined with the targeting molecule.
A press release issued on Tuesday said the Inmol director and his team felt pride in entering a new era of state-of-the-art Theranostic services with Gallium-68 PET scan, followed by targeted therapy with Lu-177-DOTA-NOC.
Most of the new products that are expected to reach the market by 2024-2026 will be labelled with Fluorine-18, Gallium-68 or Technetium-99m for the radiodiagnostics and with Lutetium-177 and Iodine-131 for the radiotherapeutic products.
Our group recently reported on fusarinine C (FSC), a cyclic siderophore based bifunctional chelator, providing a scaffold for site-specific conjugation of up to three targeting vectors with excellent complexing properties towards the PET radionuclides gallium-68 and zirconium-89 [14,15].
(8,11) Nuclear medicine studies, including indium-111 octreotide scan and gallium-68 PET/CT can assess for metastatic disease or in patients with suspected neuroendocrine gastrointestinal tumors that have failed to be detected using other modalities.
Gallium-68 ([sup.68]Ga), in particular, has received attention as an alternative positron emitter since it is not limited by the need for a nearby cyclotron and may be especially valuable in the imaging of infection/inflammation.
The physical properties of the positron emitter gallium-68 ([sup.68]Ga) and its availability from [sup.68]Ge/[sup.68]Ga generator, together with the well-known coordination chemistry of gallium, make it one of the most attractive radionuclides for PET imaging.
Biopharmaceutical company Immunomedics Inc (Nasdaq:IMMU) reported on Wednesday that results from a pretargeted study indicate that immunoPET with TF2 and a gallium-68 (68Ga)-labelled peptide is a highly specific and sensitive imaging method for colon cancer.